KoreaFilings
Cellemics (KRX: 331920)

Park Jong-gap reports 2,259,634 shares (22.74%) as co-CEO and major shareholder

insider · spotted Sep 2, 2026, 11:52 AM KST

Executive ownership of over 22% represents significant control concentration that may affect minority shareholder rights and voting outcomes on corporate decisions.

View original DART filing ↗

AI-generated summaries of public DART filings. May contain errors — always verify against the original (linked). Not investment advice.